Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

Single-point mutations within the kinase domain of BCR–ABL constitute the most frequent cause of acquired resistance to ABL kinase inhibitors in patients with chronic myeloid leukaemia (CML ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Former National Bank of Kenya (NBK) acting chief finance officer Wycliffe Kivunira Lindong’a has won a reprieve after the High Court quashed a Sh1 million fine slapped on him by the capital markets ...